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Abstract: N-hydroxyphthalimide (NHPI) is an organocatalyst for free-radical processes able 
to promote the aerobic oxidation of a wide range of organic substrates. In particular, NHPI 
can catalyze the hydroperoxidation of polyunsaturated fatty acids (PUFA). This property could 
be of interest for biological applications. This work reports the synthesis of two β-cyclodextrin 
derivatives (CD5 and CD6) having a different degree of methylation and bearing a NHPI 
moiety. These compounds, having different solubility in water, have been successfully tested 
for the hydroperoxidation of methyl linoleate, chosen as the PUFA model molecule. 
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Reactive oxygen species (ROS) are free radicals (FR) deriving from oxygen, produced as a normal 
part of metabolism within the mitochondria. External factors (i.e., smoking, UV-light exposition or 
environmental pollutants) can stimulate ROS production [1,2]. Increased levels of ROS may induce 
oxidative stress (OS), damaging proteins, DNA and RNA molecules, sugars and lipids, thus affecting 
negatively the cells structure and their functions. Different chronic diseases, such as Alzheimer’s disease, 
diabetes mellitus, hypertension, and cancer in both animals and humans, are associated to the negative 
effects of the ROS cellular overproduction. With regard to cancer, there is a considerable body of 
experimental evidence on the tumorigenesis caused by the alteration of the redox status of the cells [3,4]. 
In order to reduce the OS, several antioxidants have been proposed as ROS scavengers [5], even if not 
all the studies pointed in the same direction regarding the beneficial effects of antioxidants to prevent 
the development of cancer [6,7]. A different strategy proposed in the last few years for the treatment of 
tumors relies on the promotion of the OS instead of its inhibition. In fact, compared to normal cells, 
cancer cells exhibit higher ROS levels, but they are also more sensitive to further increments of OS [8]. 
In other words, promoting the ROS production in tumoral tissues up to cytotoxic levels would selectively 
induce apoptosis of the cancer cells [9,10]. The development of new pro-oxidant molecules able to 
enhance the OS of cancer cells has, therefore, relevant scientific interest. 
N-hydroxyphthalimide (NHPI) is an emerging organocatalyst capable of promoting free-radical 
aerobic oxidations by activating the hydrogen atom transfer processes via in situ generation of 
phthalimide-N-oxyl (PINO) radical (Scheme 1) [11–15]. NHPI has been extensively used for the 
oxidation of different organic compounds and has industrial relevance [16–22]. Due to its capability of 
catalyzing the peroxidation of lipids [23], NHPI could play a role in biomedicine as a pro-oxidant agent 
for cancer therapy. Unfortunately, the NHPI derivatives proposed in the literature for industrial use have 
been synthetized to be dissolved in liquid hydrocarbons, eventually using a co-solvent to increase their 
solubility [24,25]. Therefore, they are not suitable to be tested for the envisaged biological application. 
The synthesis of water-soluble derivatives bearing NHPI moieties could represent a valuable solution to 
tackle this problem. Moreover, the suitable choice of functional groups to be introduced into NHPI 
should also favor penetration of the cellular membrane, allowing the catalyst to manifest its pro-oxidant 
activity in the intracellular medium. Methyl-β-cyclodextrin (MeβCD), is a highly water soluble cyclic 
heptasaccharide that has been proposed in cancer therapy due to its capability to deplete cholesterol from 
the membrane cells, thus enhancing the effects of anticancer drugs [26–28]. In the present work we 
describe the synthesis of two NHPI-functionalized MeβCD derivatives, having different degrees of 
methylation, and we investigate their activities in the aerobic peroxidation of methyl linoleate, chosen 
as model molecule among the several polyunsaturated fatty acids (PUFA). Due to the synergistic action 
of the NHPI moieties, working as promoter of the oxidative stress, and MeβCD acting as lipid raft 
disrupting agent, the proposed supramolecular vectors could represent potential pro-oxidant agents in 
biological systems. 




Scheme 1. NHPI-mediated peroxidation of a generic bis-allylic derivative. 
2. Results and Discussion 
2.1. Synthesis and Characterization of NHPI-Functionalized MeβCD Derivatives 
Cyclodextrins (CDs) are macrocyclic oligosaccharides composed of 6, 7, or 8 α-[1–4]-linked  
α-D-glucopyranose units (α-, β- and γ-CD, respectively). These molecules have a truncated cone-shaped 
three-dimensional structure with an empty, hydrophobic, inner cavity. The hydroxyl groups of the 
anhydroglucose units are located both on the large rim (OH in position 2 and 3) and on the small rim of 
the truncated cone (OH in position 6). Among the three CDs, βCD is the cheapest and most used, despite 
the fact that its solubility in water at 25 °C (18.5 mg·mL−1) is lower than that of αCD (145 mg·mL−1) and 
γCD (232 mg·mL−1). The random methylation of the βCD hydroxyl groups leads to derivatives that are 
more soluble. Indeed, commercially available MeβCD, with a degree of substitution (DS, average 
number of methyl groups per glucose repeat unit) equal to 1.8, has a very high solubility in water  
(>500 mg·L−1 at 25 °C). MeβCD has found several applications in the last few years, spanning from 
pharmaceutics and health care [29] to soil remediation [30]. The capability of MeβCD to act as disruptor 
of lipid rafts selectively binding cholesterol is well documented [31], thus, offering a new tool for cancer 
therapy [26–28]. 
The synthesis of two βCD derivatives at different degrees of methylation (CD5 and CD6) and bearing 
an NHPI moiety is outlined in Scheme 2. The methylation of CD2, the mono-azide-βCD derivative, with 
two different amounts of methyl iodide, as described in the Experimental Section, afforded CD3 
(permethylated) and CD4 (random methylated). Both molecules were characterized by 1H-NMR, FT-IR 
(see Supplementary Materials for the spectra) and ESI-MS spectroscopies (see Figure 1a,b for CD3 and 
Figure 1c,d for CD4). In particular, the ESI-MS spectrum in the positive mode of CD3 shows the 
presence of peaks at m/z 1462.7 and m/z 1478.7 associated to [CD3 + Na]+ and [CD3 + K]+, respectively. 
The ESI-MS spectrum of CD4 is constituted by a more complex pattern of peaks in the range of m/z 
1250–1500. In particular, it shows the peak at m/z 1462.7 corresponding to the sodium adduct of the 
fully methylated product (analogous to CD3), and a sequence of peaks associated to the sodium adducts 
of the products with a lower number of methyl groups. Further details on the peaks distribution are 
reported in Table 1 of SI. The calculation of the average molecular weight ( WM ) and the DS of CD4 
were performed using Equations (SI1) and (SI2) in the Supplementary Materials providing the following 
values: 11355 −= molgMW and DS = 2.0. A similar DS value (1.91) was obtained from the 1H-NMR 
spectrum of CD4 in D2O. 




Scheme 2. Synthetic scheme. (a) TsCl, NaOH(aq) 0.4 M, 0 °C 8 h; (b) NaN3, DMSO, 90 °C, 
12 h; (c) dry DMF, NaH, CH3I, 0 °C, 8 h; (d) THF:H2O = 1:1 (v:v), 1, L-ascorbic acid, Cu2+, 











































































































Figure 1. ESI-MS spectra in positive mode of CD3 (a,b); CD4 (c,d); CD5 (e,f); CD6 (g,h). 
Table 1. Methyl linoleate oxidation under O2 (1 atm) at 28 °C. Conditions: 5 mmol of methyl 
linoleate, catalyst (2% mol), 1.5 mL acetonitrile, 24 h. 
Entry Catalyst Conversion 1 (%)
Selectivity 2 (%) 
TC TT 
1  5.4 62 38 
2 NHPI 42.7 49.5 50.5 
3 CD5 54.7 50.6 49.4 
4 CD6 48.0 53.8 46.2 
1 See Equation (S3) in the Supplementary Materials. 2 See Equation (S4) in the Supplementary Materials. 
The click reaction between CD3 or CD4 with the derivative 1 (but-3-yn-1-yl 2-hydroxy-1,3-
dioxoisoindoline-5-carboxylate) to afford CD5 and CD6, respectively, was carried out in THF as solvent 
in the presence of L-ascorbic acid/Cu2 + catalyst at room temperature and under a nitrogen atmosphere. 
The complete disappearance of the azide peak at 2102 cm−1 in the FT-IR spectra of both the derivatives 
(see Figure S12) was obtained in 48 h of reaction time. The FT-IR spectra of CD5 and CD6 confirmed 
the presence of a peak at 1734 cm−1, likely associated to the C=O stretching of the ester and the imide 
groups. The 1H-NMR spectrum of CD5 obtained in acetone-d6 confirmed the presence of four peaks in 
the range between 7.6 and 8.6 ppm. Three of them are attributed to the NHPI aromatic ring protons  
(7.98 ppm, d, 1H; 8.33, s, 1H; 8.44 ppm, d, 1H) and one is associated to the proton of the triazole ring 
(7.86 ppm, s, 1H). The NO–H proton is visible as broad singlet at 9.92 ppm. The anomeric protons give 
a multiplet in the range 5.05–5.40 ppm (7H) while the H-6′ protons (2H) give a doublet of doublets in 
the range of 4.90–5.00 ppm. The triplet at 4.68 ppm is attributed to the CH2 adjacent to the ester group. 
A complex pattern of overlapping peaks in the range 2.90–4.20 ppm comprises the signals associated to 
the protons of the anhydroglucose units in the positions 2, 3, 4, 5 and 6, the CH3 signals and the signal 
of CH2 adjacent to the triazole ring (102H in total). The ESI-MS spectrum of CD5 (Figure 1e,f) shows 
the presence of an intense peak at m/z 1721.7 associated to [CD5 + Na]+ with the presence of two smaller 
peaks at m/z 1699.7 ([CD5 + H]+) and m/z 1737.7 ([CD5 + K]+). The 1H-NMR spectrum of CD6 was 
obtained in DMSO-d6 with the addition of few drops of D2O in order to simplify its interpretation, which 
is similar to that of CD5. 
Interestingly, the ESI-MS spectrum of CD6 shows the presence of two sets of peaks (in the ranges 
m/z 1700–1780 and m/z 800–900). The detailed analysis of the first set of peaks (not reported) evidences 






















Molecules 2015, 20 15886 
 
 
the signals associated to the single charged sodium adducts of products at different level of methylation, 
with a distribution similar to the one of CD4. The second set of peaks is, instead, ascribed to the doubled 
charged sodium adducts. For comparison, the ESI-MS of CD6 in negative mode (see Figure S11) shows 
the presence of only one set of peaks in the range m/z 1520–1710 attributed to [CD6 − H]− at different 
levels of methylation. The average molecular weight of CD6 (1614 g·mol−1) was calculated from the 
one of CD4. 
The two derivatives, CD5 and CD6, have significantly different water solubilities. CD6 is very soluble 
in water. At 28 °C, 71.6 mg of CD6 were completely dissolved in only 76.5 mg of water obtaining a 
transparent viscous liquid. Due to the increased viscosity of the solution, no further addition of CD6 was 
carried out. Therefore, CD6 solubility is expected to exceed 950 g·L−1, a value significantly higher than 
that related to the solubility in water of simple NHPI (50.5 g·L−1) [32]. On the contrary, CD5 has a 
lower, but not negligible, solubility, as expected on the basis of its molecular structure. In fact, only  
16.0 mg could be dissolved into 860 mg of water, leading to a solubility value of just 18.8 g·L−1 at  
28 °C. These results confirm the versatility of the proposed systems, as it is possible to modulate the 
hydrophilicity/hydrophobicity of the organocatalysts by monitoring the methylation of the cavitand. This 
aspect has direct effects on the solubility of the NHPI derivative, but also allows to better-fit the structure 
chemistry for a high permeability of the cellular membrane by the supramolecular pro-oxidant. 
2.2. Catalytic Activity 
PUFA, the essential components of cellular membranes, are particularly prone to peroxidation, and, 
for this reason, methyl linoleate has been chosen as a representative substrate for testing the catalytic 
activity of CD5 and CD6 pro-oxidants. The high reactivity of these lipids towards oxygen is associated 
to the low bond dissociation energy (BDE) of the C–H bonds in the bis-allylic position (~73 Kcal/mol) [33], 
which favors hydrogen atom abstraction from peroxyl radicals. Primary products of peroxidation are two 
trans/cis hydroperoxides, deriving from the hydrogen substitution with oxygen at the 13 and 9 positions, 
and two trans/trans analogues, with a more stable geometry, formed via β-fragmentation of the 
intermediate peroxyl radicals (Scheme 1). In the absence of hydrogen donors, the mechanism may also 
include fragmentation and cyclization reactions, leading to the formation of secondary products. 
In the presence of NHPI, the reaction run faster and with higher selectivity in hydroperoxides [23]. 
In fact, hydrogen atom abstraction from bis-allylic position by PINO radical is thermodynamically favored, 
being that the O–H BDE value in the corresponding NHPI is significantly higher (88.1 Kcal/mol) [34]. 
Moreover, NHPI traps peroxyl radicals before they undergo secondary reactions, limiting the formation 
of products uniquely to hydroperoxides (Scheme 1). 
The methyl linoleate peroxidation experiments were carried out using CD5 or CD6 as catalysts, in 
the absence of an initiator and in presence of the minimum amount of acetonitrile required for obtaining 
a homogeneous mixture. For comparison, the same experiments were also carried out using NHPI. The 
identification of the peroxidation products and their quantification were obtained by 1H-NMR spectroscopy, 
following the paper of Pajunen et al. [35]. This technique is simple, fast, and reliable, and represents a 
valid alternative to the more cumbersome HPLC analysis protocol [23]. Further details can be found in 
the Supplementary Materials. 
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Different from HPLC analysis, 1H-NMR spectroscopy does not allow to distinguish the hydroperoxides 
α and β or the hydroperoxides γ and δ (see Figure 2). Therefore, α and β will be simply identified as 
“trans-trans” (TT) hydroperoxides, while γ and δ will be identified as “trans-cis” (TC) hydroperoxides. 
However, this aspect is not crucial for the scope of this work. Indeed, following the initial motivation of 
the work, oriented to the proposal of new pro-oxidant catalysts, the scope of the paper is aimed at 
demonstrating the effective capability of CD5 and CD6 in catalyzing a lipid peroxidation process 
without any particular interest for the regio- and stereoselectivity. Table 1 summarizes the experimental 
results, providing the methyl linoleate conversion and the selectivity of the oxidative process to TC and 
TT hydroperoxides. In the absence of catalyst, the autoxidation process led to a very low conversion 
(5.4%, entry 1). In the presence of CD5 (entry 3) and CD6 (entry 4), the conversions were significantly 
higher and comparable with the value associated to NHPI (entry 2). 
Figure 2. Different hydroperoxides formed during the aerobic oxidation of methyl  
linoleate catalyzed by CD-NHPI derivatives. α: Methyl 13-(R,S)-hydroperoxy-9-trans, 
11-trans-octadecadienoate; β: Methyl 9-(R,S)-hydroperoxy-10-trans,12-trans-octadecadienoate; 
γ: Methyl 13-(R,S)-hydroperoxy-9-cis,11-trans-octadecadienoate; δ: Methyl 9-(R,S)-
hydroperoxy-10-trans,12-cis-octadecadienoate. R1 = CH3(CH2)3; R2 = (CH2)5CO2CH3. 
3. Experimental Section 
3.1. General 
β-cyclodextrin (βCD) and other reagents and solvents were commercially available and used as 
received unless otherwise stated. 6A-O-p-toluenesulfonyl-βCD (CD1) was obtained according to a 
published procedure [36] with minor modifications. The corresponding monoazide derivative (CD2) 
was obtained reacting CD1 with an excess of NaN3 in DMSO at 90 °C overnight. The methylation of 
CD2 in order to obtain the derivatives CD3 and CD4 was performed in anhydrous DMF (60 mL) 
following the procedure similar to the one described by Muderawan et al. [37]. All the details are 
reported in the Supplementary Materials. 
1H-NMR spectra of the products were recorded at 305 K with a Bruker Avance-500 MHz NMR 
spectrometer (Bruker, Billerica, MA, USA). The FT-IR solid phase spectra of the powdered sample with 
infrared grade KBr were recorded using a Varian 640-IR spectrometer (Varian, Palo Alto, CA, USA). 
ESI-MS mass spectra were collected on a Bruker Esquire 3000+ with electrospray ionization source and 
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ion-trap detector. The samples were analyzed by direct infusion of suitable solutions (methanol) in the 
spectrometer source. 
3.2. Synthesis of the Derivative 1 (But-3-yn-1-yl 2-hydroxy-1,3-dioxoisoindoline-5-carboxylate) 
Trimellitic anhydride chloride (4.21 g, 20 mmol) was dissolved in 40 mL of anhydrous THF with 3 mL 
of anhydrous pyridine. Then, 20 mL of a solution of 3-butyn-1-ol (1.40 g, 20 mmol) in anhydrous THF 
were added dropwise over 1 h under stirring at 0 °C. The mixture was kept at 0 °C for 6 h and then at 
room temperature overnight. The white precipitate formed during the reaction was removed by filtration 
on paper while the solution was concentrated under vacuum. An excess of hydroxylamine hydrochloride 
(30 mmol, 2.09 g) was added to the thus-obtained syrup after diluting it with 25 mL of anhydrous 
pyridine. The mixture was stirred at room temperature for 30 min and then under reflux for 1 h in a 
microwave reactor with the automatic control of the temperature (Micro-SYNTH Labstation-Milestone 
Inc., Shelton, CT, USA). The solvent was removed under vacuum, obtaining a bright orange sticky solid 
that was finally washed with HCl (0.1 M) in a ice bath until complete removal of the residual pyridine. 
The procedure provided, in quantitative yield, an off-white solid that was used for the preparation of 
CD5 and CD6 without further purification. 1H-NMR (400 MHz, DMSO-d6): δ = 10.95 (s, 1H), 8.36 (d, 
1H), 8.20 (s, 1H), 7.98 (d, 1H), 4.41 (t, 2H, J = 6.57 Hz), 2.86 (t, 1H, J = 2.69 Hz), 2.704 (td, 2H, J1 = 6.57 
Hz, J2 = 2.69 Hz), 13C-NMR (100 MHz, DMSO-d6): 164.42, 163.62, 163.60, 135.70, 135.13, 133.05, 
129.79, 123.87, 123.15, 81.14, 72.95, 63.81, 18.77. 
3.3. Synthesis of CD5 Derivative 
CD3 (1.86g, 1.29 mmol) and 1 (670 mg, 2.58 mmol) were dissolved in 25 mL of THF under slow N2 
flow. Then, 1 mL of an aqueous solution of L-ascorbic acid (88.1 mg, 0.5 mmol), CuSO4 × 5H2O (62.4 mg, 
0.25 mmol) and Et3N (2 droplets) were added to the reaction mixture. The system was stirred at room 
temperature for 48 h under N2 atmosphere. After evaporating the solvent, the solid was transferred into 
a separatory funnel and extracted with EtOAc (3 × 100 mL). The organic phases, containing both CD5 
and the excess of 1, were collected together, dried onto anhydrous Na2SO4 and concentrated under 
vacuum. The corresponding syrup was transferred onto a silica gel column and eluted with Et2O. After 
the complete removal of the derivative 1, the product CD5 was collected by eluting the column with a 
CHCl3:MeOH (10:1) solution (about 300 mL). Finally, the orange colored organic phase was washed 
with HCl 0.1 M in a separatory funnel, dried onto anhydrous Na2SO4 and evaporated under vacuum, 
obtaining a pale yellow solid (2.05 g, ≈93.5% yield). 
3.4. Synthesis of CD6 Derivative 
CD6 was obtained following a procedure similar to CD5 from 678 mg of CD4 (0.5 mmol) and  
520 mg (2.00 mmol) of 1 dissolved in 15 mL of THF. The purification on silica gel column was carried 
out, first eluting with Et2O in order to remove the residual 1, and then with MeOH to recover the product. 
MeOH was almost completely evaporated under vacuum. The mixture was diluted in CHCl3 (150 mL) 
and washed with HCl 0.1 M in a separatory funnel. The organic phase was dried onto anhydrous Na2SO4 
and finally evaporated under vacuum, recovering a pale yellow solid (820 mg, 50.8%). 
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3.5. General Procedure for the Methyl Linoleate Aerobic Peroxidation 
The catalyst (CD5 (172.2 mg, 0.1 mmol) or CD6 (161.4 mg, 0.1 mmol) or NHPI (16.3 mg, 0.1 mmol)) 
was dissolved in 1.5 mL of acetonitrile with 5 mmol (1.472 g) of methyl linoleate. The solution was 
stirred under O2 (1 atm) at 28 °C for 24 h. Three hundred microliters of this solution were loaded onto a 
short silica gel column and eluted with hexane:ethyl acetate 1:1 (about 3 mL) in order to remove the 
catalyst. The eluent was evaporated under flux of nitrogen in about 1 h at 28 °C obtaining a transparent 
oil that was analyzed by 1H-NMR spectroscopy. Further details on the characterization are reported in the 
Supplementary Materials. 
4. Conclusions 
The synthesis of two new supramolecular pro-oxidant organocatalysts, CD5 and CD6, has been 
reported. The synthetic approach is based on the functionalization of permethylated and random methylated 
cyclodextrins with NHPI moieties by a click chemistry approach. Final products, fully characterized by 
NMR, IR and ESI-MS spectroscopic techniques, showed a completely different solubility in water 
medium, revealing how the cyclodextrin methylation degree can be an ideal tool to modulate catalyst 
solubility. Moreover, the linking of NHPI to methylated cyclodextrin cavitands, which have a higher 
affinity with cellular membranes, opens the route for the use of these catalysts as possible pro-oxidant 
agents in cancer therapy. For this reason, the catalytic activity of the new systems has been successfully 
verified in the oxidation of methyl linoleate, chosen as a representative sample as the corresponding 
cholesteryl ester as a key component of lipid membranes. Both the catalysts showed a catalytic efficiency 
analogous to that of simple NHPI, confirming how cyclodextrin functionalization does not affect NHPI 
reactivity. As expected, the oxidation process is selective in the formation of the corresponding 
hydroperoxides, without leading to the formation of secondary products. Further studies will be 
conducted in order to verify the possible catalytic activity of these systems in biological mediums. 
Supplementary Materials 
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/20/09/15881/s1. 
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